SAFE-GUARD® AquaSol Capillaria Screen Method
Evaluating Intestinal Capillaria Infection Using a Worm Screen
Newsroom
Protectotype: Mildvac-Ma5™ (Ma5) + SHOR BRON®-D (Del 072)
Effective Strategy to Combat Variant Infectious Bronchitis (IB)
MILDVAC-Ma5™ Protection
Rapid Growth and Better Antigenicity
MILDVAC-Ma5™ vs Cevac IBron®
Efficacy Evaluation of Infectious Bronchitis Virus Vaccines in Maternal Antibody Positive Broiler Chicks
INNOVAX®-ND-ILT 60 Week Duration of ND
Demonstrated 60 weeks of protection against virulent Newcastle Disease challenge in combination with Rismavac®
INNOVAX®-ND-IBD Variant IBD Protection
Return on Investment for Vaccination vs. Maternal Antibody
INNOVAX®-ND-IBD
Comparison Study using INNOVAX®-ND-IBD: Protection Against Three Common Variant IBDV Strains in US – 9109, AL-2 and Del E
INNOVAX®-ND-IBD
Demonstrated 60 weeks of protection against virulent Newcastle Disease challenge in combination with Rismavac®
INNOVAX® Dual Construct QA
Construction of rHVT Vaccines: Questions and Answers reveal that Different Approaches can achieve Effective Constructs
INNOVAX®-ND
Questions and Answers